141 related articles for article (PubMed ID: 37075641)
1. Circ_RBM23 knockdown suppresses chemoresistance, proliferation, migration and invasion of sorafenib-resistant HCC cells through miR-338-3p/RAB1B axis.
Xu C; Sun W; Liu J; Pu H; Li Y
Pathol Res Pract; 2023 May; 245():154435. PubMed ID: 37075641
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1.
Li S; Chen Z; Zhou R; Wang S; Wang W; Liu D; Li M; Guo T
Histol Histopathol; 2022 Dec; 37(12):1185-1199. PubMed ID: 35187630
[TBL] [Abstract][Full Text] [Related]
3. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
4. Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p/PD-L1 pathway.
Dou C; Zhu H; Xie X; Huang C; Tan H; Cao C
Ann Gastroenterol Surg; 2024 May; 8(3):507-520. PubMed ID: 38707229
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis.
Sun N; Gong J; Zhang W; Yang X; Liu J
Histol Histopathol; 2023 May; 38(5):537-547. PubMed ID: 35747942
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
Hao J; Du X; Lv F; Shi Q
J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase.
Chen M; Hu G; Zhou X; Peng Z; Wen W
J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259
[TBL] [Abstract][Full Text] [Related]
8. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
10. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
11. Maternal embryonic leucine zipper kinase serves as a potential prognostic marker and leads to sorafenib chemoresistance modified by miR-142-5p in hepatocellular carcinoma.
Li H; Gai L; Wu Z; Li F
Mol Biol Rep; 2022 Apr; 49(4):3015-3024. PubMed ID: 35013864
[TBL] [Abstract][Full Text] [Related]
12. Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
Wang L; Li M; Lian R
Histol Histopathol; 2022 Jul; 37(7):637-654. PubMed ID: 35133000
[TBL] [Abstract][Full Text] [Related]
13. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
15. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
16. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
17. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy.
Xu WP; Liu JP; Feng JF; Zhu CP; Yang Y; Zhou WP; Ding J; Huang CK; Cui YL; Ding CH; Zhang X; Lu B; Xie WF
Gut; 2020 Jul; 69(7):1309-1321. PubMed ID: 31727683
[TBL] [Abstract][Full Text] [Related]
18. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
Liu G; Guo W; Rao M; Qin J; Hu F; Li K
Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
[TBL] [Abstract][Full Text] [Related]
19. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
20. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]